MIRA INFORM REPORT
|
Report Date : |
05.04.2012 |
IDENTIFICATION DETAILS
|
Name : |
P.T. PRIMADAYA INDOMEDIKA |
|
|
|
|
Registered Office : |
Wisma Mitra Sunter 8th Floor |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
18.04.1996 |
|
|
|
|
Com. Reg. No.: |
No. AHU-84935.AH.01.02.TH.2008 |
|
|
|
|
Legal Form : |
Limited
Liability Company |
|
|
|
|
Line of Business : |
Trading, Import,
Supply and Distribution of Medical Equipment |
|
|
|
|
No. of Employees
: |
17 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 197,300 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Indonesia |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
P.T. PRIMADAYA INDOMEDIKA
Head Office
Wisma Mitra
Sunter 8th Floor Suite 06
Jalan Yos Sudarso Kav. 89 Block C-2
Sunter Jaya, Tanjung Priok
Jakarta Utara, 14350
Indonesia
Phones -
(62-21) 6514925-26
Fax -
(62-21) 6514788
E-mail - primadaya@bigpoint.com
Building Area - 12 storey
Office Space - 100 sq. meters
Region - Commercial
Status - Rent
18 April 1996
P.T. (Perseroan
Terbatas) or Limited Liability Company
The Ministry of Law and Human Rights
- No. C2-9461.HT.01.01.TH.96
Dated 11 October 1996
- No. C-3490.HT.01.04.TH.99
Dated 4 March 1999
- No. AHU-84935.AH.01.02.TH.2008
Dated 12 November 2008
Private National
Company
The Department
of Finance
NPWP No.
01.765.992.1-042.000
The Department
of Industry and Trade
TDP No.
090115209876
Dated 18 January
2000
None
Capital
Structure :
Authorized
Capital : Rp.
500,000,000.-
Issued Capital : Rp.
125,000,000.-
Paid up Capital : Rp.
125,000,000.-
Shareholders/Owners
:
a. Mrs. Dr.
Ratna Budiati Surya, MSc, MMed -
Rp. 37,500,000.-
Address : Jl. Raya Janur Elok PA.
26/12A, RT. 019 RW. 014
Kelurahan Pegangsaan Dua, Kecamatan Kelapa
Kelapa Gading, Jakarta
Utara
Indonesia
b. Mr. Drs.
Michael Gunadi Darmanto -
Rp. 37,500,000.-
Address : Jl. Raya Janur Elok PA.
26/12A, RT. 019 RW. 014
Kelurahan Pegangsaan Dua, Kecamatan Kelapa
Kelapa Gading, Jakarta
Utara
Indonesia
c. Mr. Raymond
Yudhistira Darmanto -
Rp. 12,500,000.-
Address : Jl. Raya Janur Elok PA.
26/12A, RT. 019 RW. 014
Kelurahan Pegangsaan Dua, Kecamatan Kelapa
Kelapa Gading, Jakarta
Utara
Indonesia
d. Ms.
Stephanie Damayanti Darmanto -
Rp. 12,500,000.-
Address : Jl. Raya Janur Elok PA.
26/12A, RT. 019 RW. 014
Kelurahan Pegangsaan Dua, Kecamatan Kelapa
Kelapa Gading, Jakarta
Utara
Indonesia
e. Mr. Timothy
Widyananda Darmanto -
Rp. 12,500,000.-
Address : Jl. Raya Janur Elok PA.
26/12A, RT. 019 RW. 014
Kelurahan Pegangsaan Dua, Kecamatan Kelapa
Kelapa Gading, Jakarta
Utara
Indonesia
f. Mr. Eugene Bramantika Darmanto - Rp.
12,500,000.-
Address :
Jl. Raya Janur Elok PA. 26/12A, RT. 019 RW. 014
Kelurahan Pegangsaan Dua, Kecamatan Kelapa
Kelapa Gading, Jakarta
Utara
Indonesia
Lines of
Business :
Trading, Import,
Supply and Distribution of Medical Equipment
Production
Capacity :
None
Total
Investment :
None
Started
Operation :
1997
Brand Name :
Primadaya
Indomedika
Technical
Assistance :
None
Number of
Employee :
17 persons
Marketing Area
:
Local - 30%
Main Customer
:
Private Hospital
and Government Hospital
Market
Situation :
Very Competitive
Main
Competitors :
a. P.T. DAYA
AGUNG MANDIRI
b. P.T. INTEGRASTA NUSANTARA
c. P.T. MURTI INDAH SENTOSA
d. P.T. ROYAL MEDICALINDO
e. Etc.
Business Trend
:
Growing
Bankers :
a. P.T. Bank
CENTRAL ASIA Tbk
Jalan Danau
Sunter Utara No. 27-28
Jakarta
Utara
Indonesia
b. P.T. Bank CIMB NIAGA Tbk
Komplek Mitra Sunter Block B-4
Jalan
Yos Sudarso Kav. 89
Jakarta Utara
Indonesia
Auditor :
Internal Auditor
Litigation :
No litigation
record in our database
Annual Sales
(estimated) :
2009 – Rp. 12.7
billion
2010 – Rp. 13.8
billion
2011 – Rp. 15.0
billion
Net Profit
(estimated) :
2009 – Rp. 0.8
billion
2010 – Rp. 0.9
billion
2011 – Rp. 1.1
billion
Payment Manner
:
Average
Financial
Comments :
Satisfactory
Board of Management :
President Director
- Mr. Drs. Michael Gunadi Darmanto
Directors -
a. Mr. Raymond Yudhistira Darmanto
b. Ms. Stephanie Damayanti Darmanto
Board of Commissioners :
Commissioner -
Mrs. Dr. Ratna Budiati Surya, M.Sc., MMed
Signatories :
President Director (Mr.
Drs. Michael Gunadi Darmanto) or one of the Directors (Mr. Raymond Yudhistira
Darmanto or Ms. Stephanie Damayanti Darmanto) which must be approved by Board
of Commissioner
Management Capability :
Good
Business Morality :
Good
Credit Risk :
Average
Credit Recommendation :
Credit should be proceeded with monitor
Proposed
Credit Limit :
Small amount –
periodical review
Maximum Credit Limit :
US$ 197,300 on 90
days D/A
P.T. PRIMADAYA INDOMEDIKA (P.T. PDIM) was set-up in Jakarta based on notary deed of Mrs. Veronica Lily Dharma, SH., No. 122 dated 18 April 1996 with the authorized capital of Rp. 50,000,000 issued capital of Rp. 12,500,000 fully and paid up. The founding shareholders of the company are Mrs. Dr. Ratna Budiati Surya, M.Sc., MMed., her husband Mr. Drs. Michael Gunadi Darmanto and Mrs. Akeh Budiarti, they are Indonesian business family of Chinese origins. The company notary deed has been changed and according notary deed of Mr. Yuliandi Ermawanto, SH., No. 15 dated 10 November 1998 the company authorized capital was increased to Rp. 500,000,000 issued capital to Rp. 125,000,000 entirely paid up. Then according to the latest revision of notary documents of Mrs. Neltje T. Pattinama, SH., No. 51 dated 15 August 2008, Mrs. Akeh Budiarti withdrew and into the company entered by Mr. Raymond Yudhistira Darmanto, Ms. Stephanie Damayanti Darmanto, Mr. Timothy Widyananda Darmanto and Mr. Eugene Bramantika Darmanto as new shareholders. With this time the composition of its shareholders has been changed to become Mrs. Dr. Ratna Budi Surya, M.Sc., MMed (30%) her husband Mr. Drs. Michael Gunandi Darmanto (30%) their son and daughter namely Mr. Raymond Yudhistira Darmanto (10%), Ms. Stephanie Damayanti Darmanto (10%), Mr. Timothy Widyananda Darmanto (10%) and Mr. Eugene Bramantika Darmanto (10%). The latest revision of notary documents was approved by the Ministry of Law and Human Rights in its decision letter No. AHU-84935.AH.01.02.TH.2008 dated November 12, 2008.
P.T. PDIM has been in operation since 1997 dealing with trading, import, supply and distribution of hospital and medical equipment. In its operation, the company trades various hospital and medical equipment such as Operating Tables, Lights & Pendants; Surgical Instruments; Patient Monitor; Ambulance & Folding Stretchers; Infant Incubators & Warmesr; Oxygen Therapy Equipment; Suction Pumps; Temperature Management; Sterilizers & Washers; Infection Control Products; Microscopes & Diagnostic Products; Stethoscopes & Sphygmomanometers; Hospital Beds & Accessories; Digital & Mechanical Scales; Respiratory Products & Nebulizers; Wheel Chairs & Mobility Products; Non-Woven Products; Packing Systems for Sterilization; Springs & Infusion Pumps; Defibrillators & AEDs; Spirometers & Audimeters etc. Its merchandise products are imported from Germany, Belgium, Switzerland, the USA, France, Poland, England, Australia, South Korea, Japan, China and others. The whole merchandise products are sold to various hospitals, health clinics, maternity hospitals in Jakarta, Bandung, Semarang, Yogyakarta, Surabaya, Bali, Medan, Palembang and other cities in the country. P.T. PDIM is classified as a medium sized company of its kind in the country of which the operation has been growing in the last three years.
Generally, demand for laboratory and medical equipment and various pharmaceutical products had been growing in the last five years up to the end 2007 as pictured in sales value of national pharmaceutical products, import value and export value issued by the Food and Drug Controlling Board (BPOM). The national pharmaceutical sales, export and import value of products are estimated to be rising by 6% to 8% in the next year. The competition is very tight on account many similar companies operating in the country.
The business position of P.T. PDIM is a sufficiently fairly good because
the company has captive market namely the state-owned hospital and private
hospital in the country. According the BPOM that national pharmaceutical sales
as shown are as the following table.
National Market Trend
of Drugs, 2001-2010 (Billion Rupiah)
|
Year |
Total Market |
Ethical Drugs |
Generic Drugs |
|
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 |
12.850 15.483 17.458 20.872 23.629 23.173 25.600 29.981 33.965 37.531 |
7.891
9.618 10.829 12.706 14.675 13.834 13.959 16.969 19.225 21,142 |
1.547 1.694 1.819 2.136 2.529 2.390 2.295 3,213 3.420 3.610 |
Source: Food and Drug Controlling Board
(BPOM)
Until this time P.T. PDIM has not been registered with Indonesian Stock Exchange, so that they shall not obliged to announce their financial statement. The management of P.T. PDIM is very reclusive towards outsiders and rejected to disclose its financial condition. We observed that total sales turnover of the company in 2009 amounted to Rp. 12.7 billion rose to Rp. 13.8 billion in 2010 increased to Rp. 15.0 billion in 2011 and projected to go on rising by at least 4% in 2012. The operation in 2011 yielded an estimated net profit of at least Rp. 1.1 billion and the company has an estimated total net worth of at least Rp. 3.0 billion. So far, we did not heard that the company having been black listed by the Central Bank (Bank Indonesia). The company usually pays its debts punctually to suppliers.
The management of P.T. PDIM is led by Mr. Drs. Michael
Gunadi Darmanto (63) a businessman and professional manager with experience in
trading, import and distribution of medical equipment. Daily operation he is
assisted by his son and daughter namely Mr. Raymond Yudhistira Darmanto (31)
and Ms. Stephanie Damayanti Darmanto (29) as Director. However the prime mover
of the company is his wife Mrs. Dr. Ratna Budiati Surya, M.Sc., MMed (58) as
Commissioner. She graduated Master of Science from University of Indonesia and
Master of Medicine from Sydney University, Australia in 2008. The company's
management is handled by professional staff in the above business. They have
wide relations with private businessmen within and outside the country. So far, we did not hear that the management of the company
being filed to the district court for detrimental cases or involved in any
business malpractices. The company’s litigation record is clean and it
has not registered with the black list of Bank of Indonesia. P.T. PRIMADAYA
INDOMEDIKA is sufficiently fairly good for business transaction.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.05 |
|
UK Pound |
1 |
Rs.81.09 |
|
Euro |
1 |
Rs.67.39 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market
trend (10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.